Autologous skin cell suspension plus phototherapy in stable vitiligo: findings from a US economic model
Among adults with stable vitiligo with prior inadequate response to topicals or phototherapy, ASCS treatment may lead to lower all-cause direct medical costs over 5 years compared to phototherapy alone.
Authors
- Nicholas Adair (ORCID: https://orcid.org/0000-0002-0581-5028)
- Matthew Sussman
- Iltefat Hamzavi (ORCID: https://orcid.org/0000-0002-3137-5601)
- Vivien Nguyen (ORCID: https://orcid.org/0000-0001-5816-5156)
- Jennifer Benner
- Brian Hitt
Institutions
- Boston University (US)
- Henry Ford Health System (US)
- Stratasys (Israel) (IL)
- Oita Medical Center (JP)
- Medica (United States) (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1080/13696998.2025.2475674
- Citations
- 1
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 1.15